Literature DB >> 6566616

Proteolytic activation of tissue plasminogen activator by plasma and tissue enzymes.

A Ichinose, W Kisiel, K Fujikawa.   

Abstract

Tissue kallikrein and factor Xa were found to activate tissue plasminogen activator (t-PA) at a rate comparable with that of plasmin. During the activation reaction, the single-chain molecule was converted into a two-chain form. A slight t-PA activating activity was also found in plasma kallikrein. Other activated coagulation factors, factor XIIa, factor XIa, factor IXa, factor VIIa, thrombin and activated protein C had no effect on t-PA activation. t-PA was also activated by a tissue kallikrein-like enzyme that was isolated from the culture medium of melanoma cells. These results indicate that tissue kallikrein and factor Xa may participate in the extrinsic pathway of human fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6566616     DOI: 10.1016/0014-5793(84)80779-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Localization of the binding site of tissue-type plasminogen activator to fibrin.

Authors:  A Ichinose; K Takio; K Fujikawa
Journal:  J Clin Invest       Date:  1986-07       Impact factor: 14.808

2.  Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.

Authors:  J I Weitz; B Leslie
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

3.  Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.

Authors:  Shan Liu; Xiaozhou Feng; Rong Jin; Guohong Li
Journal:  Expert Opin Drug Deliv       Date:  2017-09-28       Impact factor: 6.648

4.  Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution.

Authors:  Jennifer N Lilla; Ravi V Joshi; Charles S Craik; Zena Werb
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

5.  Studies on mRNA expression of tissue-type plasminogen activator in bruises for wound age estimation.

Authors:  Masataka Takamiya; Kiyoshi Saigusa; Reiko Kumagai; Nori Nakayashiki; Yasuhiro Aoki
Journal:  Int J Legal Med       Date:  2004-06-17       Impact factor: 2.686

6.  Structural and kinetic comparison of recombinant human single- and two-chain tissue plasminogen activator.

Authors:  J Loscalzo
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

7.  Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells.

Authors:  J Pöllänen; O Saksela; E M Salonen; P Andreasen; L Nielsen; K Danø; A Vaheri
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

8.  In silico and in vivo analyses of the mutated human tissue plasminogen activator (mtPA) and the antithetical effects of P19 silencing suppressor on its expression in two Nicotiana species.

Authors:  Mahshid Amiri; Mokhtar Jalali-Javaran; Raheem Haddad; Parastoo Ehsani
Journal:  Sci Rep       Date:  2018-09-19       Impact factor: 4.379

Review 9.  Impacts of tissue-type plasminogen activator (tPA) on neuronal survival.

Authors:  Arnaud Chevilley; Flavie Lesept; Sophie Lenoir; Carine Ali; Jérôme Parcq; Denis Vivien
Journal:  Front Cell Neurosci       Date:  2015-10-16       Impact factor: 5.505

10.  Two-Chains Tissue Plasminogen Activator Unifies Met and NMDA Receptor Signalling to Control Neuronal Survival.

Authors:  Elodie Hedou; Sara Douceau; Arnaud Chevilley; Alexandre Varangot; Audrey M Thiebaut; Hortense Triniac; Isabelle Bardou; Carine Ali; Mike Maillasson; Tiziana Crepaldi; Paolo Comoglio; Eloïse Lemarchand; Véronique Agin; Benoit D Roussel; Denis Vivien
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.